S81474 |
Hesperadin |
源葉(MedMol) | ≥98% |
品牌 | 貨號(hào) | 產(chǎn)品規(guī)格 | 價(jià)格(RMB) | 庫(kù)存(上海) | 北京 | 武漢 | 南京 | 數(shù)量 | 計(jì)量單位 | 加入購(gòu)物車(chē)... |
---|---|---|---|---|---|---|---|---|---|---|
源葉(MedMol) | S81474-5mg | ≥98% | ¥760.00元 | 10 | - | - | - | EA | 加入購(gòu)物車(chē) | |
源葉(MedMol) | S81474-25mg | ≥98% | ¥3042.00元 | 8 | - | - | - | EA | 加入購(gòu)物車(chē) | |
源葉(MedMol) | S81474-100mg | ≥98% | ¥8239.00元 | 預(yù)計(jì)交期:2-3天 | - | - | - | EA | 加入購(gòu)物車(chē) |
- 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
- 產(chǎn)品描述: Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM. Hesperadin inhibits the growth of Trypanosoma brucei by blocking nuclear division and cytokinesis. Hesperadin also is a broad-spectrum influenza antiviral
- 靶點(diǎn): Trypanosoma;Aurora B:250 nM (IC50);InfluenzaVirus;?Parasite;?AuroraKinase;?Autophagy
- 體內(nèi)研究:
Hesperadin (20 mg/kg/d; i.v.) prolongs the survival of xenograft mice via synergistic effect with temozolomide (TMZ)
- 參考文獻(xiàn):
1. Neal J, et, al. The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in bloodstream forms. Mol Microbiol. 2009 Apr; 72(2): 442-58. 2. Wahafu A, et, al. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide. Pathol Res Pract. 2019 Nov; 215(11): 152617. 3. Hu Y, et, al. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci. 2017 Sep 8;18(9):1929.
- 溶解性: Soluble in DMSO
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.935 ml 9.677 ml 19.355 ml 5 mM 0.387 ml 1.935 ml 3.871 ml 10 mM 0.194 ml 0.968 ml 1.935 ml 50 mM 0.039 ml 0.194 ml 0.387 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)
=**